Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Neuroplastogen
Therapeutic Area : Psychiatry/Psychology
Study Phase : Discovery
Sponsor : CRC-P
Deal Size : $3.0 million
Deal Type : Funding
$3M Grant Awarded to Develop Neuroplastogens for Substance Use Treatment
Details : The funding will focus on the development of neuroplastogens for the treatment of substance use disorders, with an emphasis on methamphetamine addiction.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
October 28, 2024
Lead Product(s) : Neuroplastogen
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Discovery
Sponsor : CRC-P
Deal Size : $3.0 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?